載入...
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1
Immune checkpoint inhibitors (ICIs) have dramatically modified the prognosis of several advanced cancers, however many patients still do not respond to treatment. Optimal results might be obtained by targeting cancer cell metabolism to modulate the immunosuppressive tumor microenvironment. Here, we...
Na minha lista:
| 發表在: | Nat Commun |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6978345/ https://ncbi.nlm.nih.gov/pubmed/31974367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-019-14218-7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|